⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INBX News
Inhibrx Biosciences, Inc. Common Stock
Form 8-K
sec.gov
INBX
Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
prnewswire.com
INBX
Form 8-K
sec.gov
INBX
Form 8-K
sec.gov
INBX
Inhibrx Reports First Quarter 2026 Financial Results
prnewswire.com
INBX
Form 8-K
sec.gov
INBX
Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy
prnewswire.com
INBX
Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC
prnewswire.com
INBX
Form 8-K
sec.gov
INBX
Inhibrx To Host Webcast Presentation to Provide Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer
prnewswire.com
INBX